Apollo Hospitals Enterprise Limited
APOLLOHOSP · Hospitals · NSE
₹8,469
Current Market Price
Fair Value (DCF)
₹3,779
Discount to FV
-55.4%
Updated 4h ago
YieldIQ Score
40/100
Piotroski F-Score
6/9
Economic Moat
Narrow
Confidence
35%
ROE
20.5%
Debt/Equity
0.90
WACC
9.5%
Market Cap
₹1.22 Lakh Cr
Quality & Valuation
Neutral model outputs — no recommendations.
ROCE
22.2%
Return on capital employed
EV / EBITDA
28.7×
Enterprise multiple
Debt / EBITDA
2.1×
Leverage vs earnings
Interest Coverage
6.9×
EBIT covers interest
Current Ratio
1.06×
Short-term liquidity
Asset Turnover
1.14×
Revenue per ₹ of assets
Revenue CAGR (3Y)
15.3%
3-year revenue growth
Revenue CAGR (5Y)
19.0%
5-year revenue growth
DCF Scenario Analysis
vs CMP ₹8,468.5
Bear case
Margin of Safety —
Implied upside -277.4%
Base case
Margin of Safety —
Implied upside -124.1%
Bull case
Margin of Safety -212.6%
Implied upside -68.0%
Ratio Trends
APOLLOHOSP · last 9 annual periods
ROE
20.5%
ROCE
22.2%
Operating Margin
—
Debt / Equity
0.90×
PE
54.9×
EV / EBITDA
28.7×
Historical Financials
APOLLOHOSP · Annual, last 5 years· amounts in ₹Cr unless noted
| Metric | 2022 NSE_XBRL | 2023 NSE_XBRL | 2024 NSE_XBRL | 2025 yfinance | 2026 yfinance | CAGR |
|---|---|---|---|---|---|---|
| Revenue | ₹14.5K Cr | ₹16.4K Cr | ₹18.9K Cr | ₹21.8K Cr | ₹25.2K Cr | +14.8% |
| EBITDA | ₹2509 Cr | ₹2073 Cr | ₹2478 Cr | ₹3255 Cr | ₹3987 Cr | +12.3% |
| EBIT | ₹1957 Cr | ₹1525 Cr | ₹1812 Cr | — | — | -1.9% |
| PAT | ₹1056 Cr | ₹819 Cr | ₹899 Cr | ₹1446 Cr | ₹1942 Cr | +16.5% |
| EPS (diluted) | ₹73.42 | ₹56.97 | ₹62.50 | — | — | -3.9% |
| CFO | ₹1696 Cr | ₹1377 Cr | ₹1920 Cr | ₹2136 Cr | ₹2856 Cr | +13.9% |
| CapEx | ₹-657 Cr | ₹-1129 Cr | ₹-1137 Cr | ₹-1713 Cr | ₹-1962 Cr | — |
| FCF | ₹1039 Cr | ₹248 Cr | ₹783 Cr | ₹424 Cr | ₹894 Cr | -3.7% |
| Total Assets | ₹13.3K Cr | ₹14.4K Cr | ₹16.8K Cr | ₹20.7K Cr | ₹22.2K Cr | +13.7% |
| Total Debt | ₹4068 Cr | ₹4332 Cr | ₹5333 Cr | ₹5419 Cr | ₹8493 Cr | +20.2% |
| Shareholders' Equity | ₹5623 Cr | ₹6197 Cr | ₹6935 Cr | ₹8212 Cr | ₹9480 Cr | +13.9% |
CAGR computed across the visible window. Signs reverse if start value is zero or negative.
Peer Comparison
APOLLOHOSP vs 5 closest peers by market-cap band
| Peer | MoS | Score | Verdict | ROE | PE |
|---|---|---|---|---|---|
 MAXHEALTH Max Healthcare Institute Limited | -120.8%-54.7% upside | 40 | Above Fair Value | 13.4% | — |
 FORTIS Fortis Healthcare Limited | -132.6%-57.0% upside | 40 | Above Fair Value | 10.5% | 57.6× |
 ASTERDM ASTERDM | — | — | Pending | 156.9% | — |
 NH Narayana Hrudayalaya Ltd. | -166.0%-62.4% upside | 35 | Above Fair Value | 17.8% | — |
 MEDANTA Global Health Limited | -290.6%-74.4% upside | 40 | Data Limited | 14.1% | — |
Click a ticker to view its fair-value analysis.
Dividend History
14 ex-dividend events on file. Source: NSE corporate-actions feed.
Total paid (5Y)
₹74.75/sh
Last payout
2026-02-16
₹10.00
Peak payout
₹11.75
Trailing yield
0.24%
Amounts parsed from NSE subject lines. Percent-of-face-value declarations are converted using the per-ticker face value (defaults to ₹10).
AI Analysis Summary
Model-generated description of metrics. Not investment advice. Apollo Hospitals Enterprise Limited (APOLLOHOSP.NS) trades at 8468.50 vs a model fair value of 3778.75, a gap of -55.4%. Piotroski F-scor...
Read full AI analysis →Reverse DCF
Market-implied growth
What FCF growth is priced in →
Risk Analysis
Volatility & drawdown
Risk profile of APOLLOHOSP →
DuPont
ROE decomposition
Why ROE is what it is →
Technicals
RSI, MACD, MAs
Reference indicators →
News & Filings
Recent activity
BSE filings + news for APOLLOHOSP →
Compare
Head-to-head with peers
Compare APOLLOHOSP side by side →
Run Full Interactive Analysis
Interactive DCF sliders, sensitivity heatmap, peer comparison, and more.
Analyse APOLLOHOSPNow →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future results.